Search Results - "Eduardo Díaz-rubio" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

by SALTZ, Leonard B, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, CASSIDY, Jim, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando
Published in Journal of clinical oncology (20.04.2008)

Get full text

Journal Article

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

by CASSIDY, Jim, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, SALTZ, Leonard, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando
Published in Journal of clinical oncology (20.04.2008)

Get full text

Journal Article

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

by García-Foncillas, Jesús, Tabernero, Josep, Élez, Elena, Aranda, Enrique, Benavides, Manuel, Camps, Carlos, Jantus-Lewintre, Eloisa, López, Rafael, Muinelo-Romay, Laura, Montagut, Clara, Antón, Antonio, López, Guillermo, Díaz-Rubio, Eduardo, Rojo, Federico, Vivancos, Ana
Published in British journal of cancer (01.12.2018)

Get full text

Journal Article

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

by Díaz‐Rubio, Eduardo, Gómez‐España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Abad, Albert, Valladares, Manuel, Rivera, Fernando, Safont, Maria J., Martínez de Prado, Purificación, Gallén, Manuel, González, Encarnación, Marcuello, Eugenio, Benavides, Manuel, Fernández‐Martos, Carlos, Losa, Ferrán, Escudero, Pilar, Arrivi, Antonio, Cervantes, Andrés, Dueñas, Rosario, López‐Ladrón, Amelia, Lacasta, Adelaida, Llanos, Marta, Tabernero, Jose M., Antón, Antonio, Aranda, Enrique
Published in The oncologist (Dayton, Ohio) (01.01.2012)

Get full text

Journal Article

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database

by Shi, Qian, de Gramont, Aimery, Grothey, Axel, Zalcberg, John, Chibaudel, Benoist, Schmoll, Hans-Joachim, Seymour, Matthew T, Adams, Richard, Saltz, Leonard, Goldberg, Richard M, Punt, Cornelis J A, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Hurwitz, Herbert, Díaz-Rubio, Eduardo, Porschen, Rainer, Tebbutt, Niall C, Fuchs, Charles, Souglakos, John, Falcone, Alfredo, Tournigand, Christophe, Kabbinavar, Fairooz F, Heinemann, Volker, Van Cutsem, Eric, Bokemeyer, Carsten, Buyse, Marc, Sargent, Daniel J
Published in Journal of clinical oncology (01.01.2015)

Get full text

Journal Article

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

by Mira, Emilia, Carmona-Rodríguez, Lorena, Pérez-Villamil, Beatriz, Casas, Josefina, Fernández-Aceñero, María Jesús, Martínez-Rey, Diego, Martín-González, Paula, Heras-Murillo, Ignacio, Paz-Cabezas, Mateo, Tardáguila, Manuel, Oury, Tim D, Martín-Puig, Silvia, Lacalle, Rosa Ana, Fabriás, Gemma, Díaz-Rubio, Eduardo, Mañes, Santos
Published in Nature communications (08.02.2018)

Get full text

Journal Article

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

by Tabernero, Josep, Van Cutsem, Eric, Díaz-Rubio, Eduardo, Cervantes, Andrés, Humblet, Yves, André, Thierry, Van Laethem, Jean-Luc, Soulié, Patrick, Casado, Esther, Verslype, Chris, Valera, Javier Sastre, Tortora, Giampaolo, Ciardiello, Fortunato, Kisker, Oliver, de Gramont, Aimery
Published in Journal of clinical oncology (20.11.2007)

Get full text

Journal Article

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

by DIAZ-RUBIO, Eduardo, TABERNERO, Jose, MAUREL, Joan, GONZALEZ-FLORES, Encarnacion, APARICIO, Jorge, RIVERA, Fernando, LOSA, Ferran, ARANDA, Enrique, GOMEZ-ESPANA, Auxiliadora, MASSUTI, Bartomeu, SASTRE, Javier, CHAVES, Manuel, ABAD, Alberto, CARRATO, Alfredo, QUERALT, Bernardo, REINA, Juan José
Published in Journal of clinical oncology (20.09.2007)

Get full text

Journal Article

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

by Sastre, Javier, Maestro, M. Luisa, Gómez‐España, Auxiliadora, Rivera, Fernando, Valladares, Manuel, Massuti, Bartomeu, Benavides, Manuel, Gallén, Manuel, Marcuello, Eugenio, Abad, Albert, Arrivi, Antonio, Fernández‐Martos, Carlos, González, Encarnación, Tabernero, Josep M., Vidaurreta, Marta, Aranda, Enrique, Díaz‐Rubio, Eduardo
Published in The oncologist (Dayton, Ohio) (01.07.2012)

Get full text

Journal Article

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

by Sastre, Javier, Grávalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares‐Ayerbes, Manuel, Marcuello, Eugenio, Manzano, José L., Benavides, Manuel, Hidalgo, Manuel, Díaz‐Rubio, Eduardo, Aranda, Enrique
Published in The oncologist (Dayton, Ohio) (01.03.2012)

Get full text

Journal Article

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

by Aguado, Carlos, García-Paredes, Beatriz, Sotelo, Miguel Jhonatan, Sastre, Javier, Díaz-Rubio, Eduardo
Published in World journal of gastroenterology : WJG (28.05.2014)

Get full text

Journal Article

Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets

Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets

by Paz-Cabezas, Mateo, Calvo-López, Tania, Romera-Lopez, Alejandro, Tabas-Madrid, Daniel, Ogando, Jesus, Fernández-Aceñero, María-Jesús, Sastre, Javier, Pascual-Montano, Alberto, Mañes, Santos, Díaz-Rubio, Eduardo, Perez-Villamil, Beatriz
Published in Cancers (22.10.2022)

Get full text

Journal Article

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy

by Cabezas‐Camarero, Santiago, de la Orden García, Virginia, García‐Barberán, Vanesa, Mediero‐Valeros, Beatriz, Subhi‐Issa, Ahmad Issa, Llovet García, Patricia, Bando‐Polaino, Inmaculada, Merino Menéndez, Salomé, Pérez‐Segura, Pedro, Díaz‐Rubio, Eduardo
Published in The oncologist (Dayton, Ohio) (01.03.2019)

Get full text

Journal Article

Role of cetuximab in first-line treatment of metastatic colorectal cancer

Role of cetuximab in first-line treatment of metastatic colorectal cancer

by Sotelo, Miguel Jhonatan
Published in World journal of gastroenterology : WJG (21.04.2014)

Get full text

Journal Article

Continuing Single‐Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First‐Line Treatment of Metastatic Colorectal Cancer

Continuing Single‐Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First‐Line Treatment of Metastatic Colorectal Cancer

by Díaz‐Rubio, Eduardo, Pietrantonio, Filippo, Braud, Filippo
Published in The oncologist (Dayton, Ohio) (01.11.2012)

Get full text

Journal Article

Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome

Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome

by Lorca, Víctor, Rueda, Daniel, Martín-Morales, Lorena, Poves, Carmen, Fernández-Aceñero, María Jesús, Ruiz-Ponte, Clara, Llovet, Patricia, Marrupe, David, García-Barberán, Vanesa, García-Paredes, Beatriz, Pérez-Segura, Pedro, de la Hoya, Miguel, Díaz-Rubio, Eduardo, Caldés, Trinidad, Garre, Pilar
Published in PloS one (02.11.2017)

Get full text

Journal Article Web Resource

Chemotherapy for gastric cancer

Chemotherapy for gastric cancer

by Javier Sastre Jose Angel García-Saenz Eduardo Díaz-Rubio
Published in World journal of gastroenterology : WJG (14.01.2006)

Get full text

Journal Article

About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

by Gutiérrez‐Enríquez, Sara, Bonache, Sandra, Ruíz de Garibay, Gorka, Osorio, Ana, Santamariña, Marta, Ramón y Cajal, Teresa, Esteban‐Cardeñosa, Eva, Tenés, Anna, Yanowsky, Kira, Barroso, Alicia, Montalban, Gemma, Blanco, Ana, Cornet, Mònica, Gadea, Neus, Infante, Mar, Caldés, Trinidad, Díaz‐Rubio, Eduardo, Balmaña, Judith, Lasa, Adriana, Vega, Ana, Benítez, Javier, la Hoya, Miguel, Diez, Orland
Published in International journal of cancer (01.05.2014)

Get full text

Journal Article

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

by Martín, Miguel, Custodio, Sara, Casas, Maria‐Luisa Maestro, García‐Sáenz, José‐Ángel, Torre, Julio‐César, Bellón‐Cano, Jose‐María, López‐Tarruella, Sara, Vidaurreta‐Lazaro, Marta, Orden, Virginia, Jerez, Yolanda, Márquez‐Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz‐Rubio, Eduardo
Published in The oncologist (Dayton, Ohio) (01.08.2013)

Get full text

Journal Article

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

by Romero, Atocha, Pérez-Segura, Pedro, Tosar, Alicia, García-Saenz, José Ángel, Díaz-Rubio, Eduardo, Caldés, Trinidad, de la Hoya, Miguel
Published in Breast cancer research and treatment (01.10.2011)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[16]